Alnylam Pharmaceuticals Company

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Industry: Atrificial Vectors and Immune Cells, RNA
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2002-01-01
Employees Number: 1001-5000
Funding Status: IPO
Investors Number: 11
Total Funding: 2500000000
Estimated Revenue: $100M to $500M
Last Funding Date: 2020-04-13
Last Funding Type: Post-IPO Debt

Visit Website
Register and Claim Ownership